Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS)

CNY 8.44

(0.12%)

Market Cap (In CNY)

9.8 Billion

Revenue (In CNY)

10.37 Billion

Net Income (In CNY)

-93.17 Million

Avg. Volume

7.48 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.43-9.84
PE
-
EPS
-
Beta Value
0.384
ISIN
CNE0000013Z2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Weihong Xiao
Employee Count
-
Website
https://www.hisunpharm.com
Ipo Date
2000-07-25
Details
Zhejiang Hisun Pharmaceutical Co., Ltd. manufactures and supplies pharmaceutical products in China. It provides active pharmaceutical ingredients and finished dosage form products. The company offers products in the areas of anti-tumor, cardiovascular, anti-infective, liver care, orthopedics, anticancer, anti-parasitic, immunosuppressant, etc.; and weight loss, anti-viral, anti-TB, veterinary pharma, and others. It also provides product consultation and CMO/CRO manufacturing services. The company was founded in 1956 and is headquartered in Taizhou, China.